TABLE 4
For GHK-Cu, whether the endpoint is skin, joint, or vascular tissue repair, localized depot release via SubQ outperforms IM systemic distribution
Thus, the focus of KOA management remains on alleviating inflammatory conditions [35]
Even-toned skin from head-to-toe: Glutone by virtue of Setria Glutathione exerts beneficial effects on cellular function
Comprehensive Lab Testing Legitimate peptide therapy requires baseline and monitoring labs: Before treatment: Hormone panels, metabolic panels, lipids, inflammatory markers, kidney/liver function During treatment: Regular monitoring of relevant biomarkers (IGF-1 for GH peptides, glucose/HbA1c for GLP-1s) Advanced testing when indicated: DUTCH hormone testing, nutrient panels, genetic markers Why this matters: You cant optimize what you dont measure